Are digital devices a new risk factor for myopia?

Competing Interests: JL has received research grant funding support from Health Research Board (Ireland), Nevakar and Coopervision; has consultancy relationships with Dopavision, Kubota Vision, Ocuco, and Ebiga Vision; has received honoraria from Thea Pharmaceuticals and Ocuco for lectures; has received equipment on loan from Topcon and Coopervision; has two patents pending (one in myopia management data analytics and one in biomonitoring for low dose atropine treament in myopia); and is Director of Ocumetra, all in the field of myopia management. DIF has received research grant funding support from Health Research Board (Ireland), Nevakar, and Coopervision; has consultancy relationships with Dopavision, Kubota Vision, Essilor, and Johnson & Johnson; has received equipment on loan from Topcon and Coopervision; has two patents pending (one in myopia management data analytics and one in biomonitoring for low dose atropine treament in myopia); and is Director of Ocumetra, all in the field of myopia management. DIF has also previously collaborated with one of the Article authors (RRAB) on published work.